Clinical trial
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment…
NCT00451646 · Fresenius Kabi, Industry · Completed
Key facts
| NCT number | NCT00451646 |
|---|---|
| Title | Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition |
| Official title | A Double-blind, Randomised Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition |
| Lead sponsor | Fresenius Kabi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parenteral Nutrition |
| Intervention type | Drug |
| Interventions | SMOF lipid and Intralipid |
| Enrollment | 75 |
| Start date | Oct 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Mar 23, 2007 |
| Last update posted | Aug 27, 2010 |
| Countries | Australia, Denmark, France, Israel, Netherlands, Poland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: